XXXX and @entity242 . A case for aggressive search and destroy.

@entity1 @entity10189 @entity706 @entity242 @entity5 @entity409 @entity344 @entity1820
The incidence of @entity242 of the gastrointestinal tract has remained the same, but @entity344 are gradually contributing a larger percentage of @entity1820 . The authors have examined their more recent experience with these relatively rare lesions. Twenty-eight @entity1 (13 with @entity706 , 15 with @entity242 ) have been treated at the Vanderbilt University and the Metropolitan Nashville General Hospital since 1976. There were eight @entity1 in the group with @entity706 and six in the group with @entity242 . The average age for @entity1 with @entity706 was 66 years; the average age was 57 years in the @entity1 with @entity242 . Seven @entity1 with @entity706 and eight @entity1 with @entity242 had been treated for 6 months to 3 years for presumed @entity10189 . Eight of these 15 @entity1 were found to have perforated @entity5 at the time of surgical exploration. Three @entity1 (all in the group with @entity242 ) had metastatic @entity409 or peritoneal implants at the time of diagnosis. Treatment for most @entity1 included resection of the @entity5 , followed by chemotherapy or radiation in cases of @entity5 perforation or metastatic disease. The survival rate for @entity1 with @entity706 has averaged 5.5 years, with a 55% 5-year survival rate. @entity1 with cleaved cell @entity5 survived longer than those with other types of @entity706 . In the group with @entity242 , the survival rate has been 3.1 years on the average, with a 21% 5-year survival rate.
